US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 15.6900
- +0.6700+4.46%
Close Aug 23 16:00 ET
- 15.4300
- -0.2600-1.66%
Post 19:25 ET
1.06BMarket Cap-9451P/E (TTM)
15.8200High15.1100Low690.78KVolume15.1100Open15.0200Pre Close10.78MTurnover1.59%Turnover RatioLossP/E (Static)67.43MShares19.050052wk High3.10P/B680.29MFloat Cap2.050052wk Low--Dividend TTM43.36MShs Float85.0000Historical High--Div YieldTTM4.73%Amplitude0.0300Historical Low15.6000Avg Price1Lot Size
About Perspective Therapeutics Company
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Company Profile
SymbolCATX
Company NamePerspective Therapeutics
Listing DateApr 19, 2007
Founded1983
CEOMr. Johan M. (Thijs) Spoor
MarketAMEX
Employees119
Fiscal Year Ends12-31
Address2401 Elliott Avenue,Suite 320
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98121
Phone1-206-676-0900
Company Executives
- Name
- Position
- Salary
- Johan M. (Thijs) Spoor
- Director and Chief Executive Officer
- 1.46M
- Dr. Markus Puhlmann, M.D.,PhD
- Chief Medical Officer
- 900.09K
- Jonathan R. Hunt
- Principal Financial Officer and Principal Accounting Officer
- 1.17M
- Lori A. Woods
- Chairman of the Board
- 671.73K
- Dr. Frank Morich, M.D.,PhD
- Independent Director
- 320.06K
- Heidi Henson, C.P.A.
- Independent Director
- 390.70K
- Robert Froman Willian, III
- Independent Director
- 320.06K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg